VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $67,207,000 | +20.9% | 4,221,500 | +57.8% | 3.73% | -14.2% |
| Q4 2017 | $55,592,000 | +187.6% | 2,675,259 | +98.3% | 4.35% | +122.0% |
| Q3 2017 | $19,332,000 | -31.1% | 1,349,059 | -16.9% | 1.96% | -23.1% |
| Q2 2017 | $28,073,000 | +9.9% | 1,622,688 | -29.9% | 2.55% | +11.5% |
| Q1 2017 | $25,544,000 | +76.5% | 2,315,900 | +132.4% | 2.28% | +55.3% |
| Q4 2016 | $14,470,000 | +31.8% | 996,589 | +122.8% | 1.47% | +37.1% |
| Q3 2016 | $10,982,000 | +27.9% | 447,351 | +4.9% | 1.07% | +39.7% |
| Q2 2016 | $8,587,000 | +165.9% | 426,381 | +247.1% | 0.77% | +143.8% |
| Q1 2016 | $3,230,000 | – | 122,831 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |